LCD and Article Updates for September 2020

The medical policies and related articles can be found in our Medical Policy Center.

Article update for August

Billing and Coding: Bevacizumab and biosimilars (A52370)

ICD-10-CM codes C22.0, C22.8 and C22.9 were inadvertently added with an incorrect effective date. The effective date has been corrected to 5/29/2020 based on the FDA label.

The following language has been added to the ICD-10 Codes that Support Medical Necessity Group 1 paragraph section:

The annual ICD-10 CM updates, 2020-2021 were applied to the Article Databases. Based on this ICD-10-CM code G96.8 has been deleted from the Group 1 Codes but is effective until 9/30/2020.

Based on a Part B provider comment, ICD-10-CM code Z80.49 has been removed from the Group 1 ICD-10 code list and replaced with Z85.44.

Future Effective LCDs

Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH) (L38367)

The Notice period has been extended to 10/31/2020. The Notice period start date has been changed to 8/31/2020. The Revision Effective Date has been changed from 9/1/2020 to 11/1/2020.

Transcranial Magnetic Stimulation (L33398)

The Notice period has been extended to 9/30/2020. The Notice Period start date has been changed to 8/6/2020. The Revision Effective date has been changed from 8/1/2020 to 10/1/2020.

Posted 8/25/2020